Author:
Maggino Tiziano,Sciarrone Rocco,Murer Bruno,Dei Rossi Maria Rosa,Fedato Chiara,Maran Michela,Lorio Melania,Soldà Marika,Zago Fiorella,Rossi Paolo Giorgi,Zorzi Manuel
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, von Karsa L (2010) European guidelines for quality assurance in cervical cancer screening. Second edition-summary document. Ann Oncol 21: 448–458.
2. Arbyn M, Ronco G, Anttila A, CJLM Meijer, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J (2012) Evidence regarding HPV testing in secondary prevention of cervical cancer. Vaccine 30 (Suppl 5): F88–F99.
3. Arbyn M, Haelens A, Desomer A, Verdoodt F, Thiry N, Francart J, Hanquet G, Robays J (2015a) Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: update on HPV primary screening. Health Technology Assessment (HTA). Brussels: Belgian Health Care Knowledge Centre (KCE). KCE Reports 238: D/2015/10.273/17.
4. Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, Poljak M (2015b) Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect 21: 817–826.
5. Baussano I, Franceschi S, Gillio-Tos A, Carozzi F, Confortini M, Dalla Palma P, De Lillo M, Del Mistro A, De Marco L, Naldoni C, Pierotti P, Schincaglia P, Segnan N, Zorzi M, Giorgi-Rossi P, Ronco G (2013) Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial. BMC Infect Dis 13: 238.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献